136 related articles for article (PubMed ID: 15195109)
1. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.
Bellei B; Pacchiarotti A; Perez M; Faraggiana T
Mod Pathol; 2004 Oct; 17(10):1275-81. PubMed ID: 15195109
[TBL] [Abstract][Full Text] [Related]
2. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
3. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.
Bellei B; Cota C; Amantea A; Muscardin L; Picardo M
Br J Dermatol; 2006 Dec; 155(6):1223-9. PubMed ID: 17107393
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
6. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
[TBL] [Abstract][Full Text] [Related]
7. Mutations of p53, c-kit, K-ras, and beta-catenin gene in non-Hodgkin's lymphoma of adrenal gland.
Nakatsuka S; Hongyo T; Syaifudin M; Nomura T; Shingu N; Aozasa K
Jpn J Cancer Res; 2002 Mar; 93(3):267-74. PubMed ID: 11927008
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
9. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.
Rimm DL; Caca K; Hu G; Harrison FB; Fearon ER
Am J Pathol; 1999 Feb; 154(2):325-9. PubMed ID: 10027390
[TBL] [Abstract][Full Text] [Related]
10. Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines.
Pollock PM; Hayward N
Melanoma Res; 2002 Apr; 12(2):183-6. PubMed ID: 11930117
[TBL] [Abstract][Full Text] [Related]
11. Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines.
Woo DK; Kim HS; Lee HS; Kang YH; Yang HK; Kim WH
Int J Cancer; 2001 Mar; 95(2):108-13. PubMed ID: 11241321
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Adachi T; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Arch Pathol Lab Med; 2002 Sep; 126(9):1071-8. PubMed ID: 12204056
[TBL] [Abstract][Full Text] [Related]
13. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
14. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis.
Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Yabu M; Himeno S; Imanishi K; Ohsawa M; Wada H; Tominaga S; Shimano T; Kobayashi T; Nakamura Y
Cancer Lett; 2000 Oct; 159(1):73-8. PubMed ID: 10974408
[TBL] [Abstract][Full Text] [Related]
15. Detection and analysis of beta-catenin mutations in prostate cancer.
Chesire DR; Ewing CM; Sauvageot J; Bova GS; Isaacs WB
Prostate; 2000 Dec; 45(4):323-34. PubMed ID: 11102958
[TBL] [Abstract][Full Text] [Related]
16. beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome.
de Castro J; Gamallo C; Palacios J; Moreno-Bueno G; Rodríguez N; Feliu J; González-Barón M
Virchows Arch; 2000 Dec; 437(6):599-604. PubMed ID: 11193470
[TBL] [Abstract][Full Text] [Related]
17. IgV(H) and bcl6 somatic mutation analysis reveals the heterogeneity of cutaneous B-cell lymphoma, and indicates the presence of undisclosed local antigens.
Franco R; Camacho FI; Fernández-Vázquez A; Algara P; Rodríguez-Peralto JL; De Rosa G; Piris MA
Mod Pathol; 2004 Jun; 17(6):623-30. PubMed ID: 15098010
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.
Zhu X; Kanai Y; Saito A; Kondo Y; Hirohashi S
Pathol Int; 2000 Dec; 50(12):945-52. PubMed ID: 11123760
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of primary cutaneous lymphomas in Tehran, Iran (1998-2004).
Manuchehri HM; Rakhshan M
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):758-60. PubMed ID: 16836523
[No Abstract] [Full Text] [Related]
20. Evaluation of classic architectural criteria in non-mycosis fungoides cutaneous lymphomas.
Glusac EJ; Kindel SE; Soslow RA; Smoller BR
Am J Dermatopathol; 1997 Dec; 19(6):557-61. PubMed ID: 9415610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
